The more we hear about probiotics, the better they sound. br
The latest study results tell us that science may be one step closer to treating diabetes with a human probiotic pill, according to new Cornell University research.
Researchers engineered a strain of lactobacillus, a human probiotic common in the gut, to secrete a Glucagon-like peptide. They then administered it orally to diabetic rats for 90 days and found that the rats receiving the engineered probiotic had up to 30 percent lower high blood glucose, a hallmark of diabetes.
The study was proof of principle, and future work will test higher doses to see if a complete treatment can be achieved, said John March, professor of biological and environmental engineering at Cornell University.
--Sarah Hagerty
